Classification of current anticancer immunotherapies. Read more about Classification of current anticancer immunotherapies.
The cylindromatosis gene product, CYLD, interacts with MIB2 to regulate notch signalling. Read more about The cylindromatosis gene product, CYLD, interacts with MIB2 to regulate notch signalling.
DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells. Read more about DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells.
Epigenetic suppression of EGFR signaling in G-CIMP+ glioblastomas. Read more about Epigenetic suppression of EGFR signaling in G-CIMP+ glioblastomas.
Mutant NRASQ61 shares signaling similarities across various cancer types--potential implications for future therapies. Read more about Mutant NRASQ61 shares signaling similarities across various cancer types--potential implications for future therapies.
RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth. Read more about RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth.
Extracellular activation of Wnt signaling through epigenetic dysregulation of Wnt inhibitory factor-1 (Wif-1) is associated with pathogenesis of adrenocortical tumor. Read more about Extracellular activation of Wnt signaling through epigenetic dysregulation of Wnt inhibitory factor-1 (Wif-1) is associated with pathogenesis of adrenocortical tumor.
The IncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer. Read more about The IncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer.
Drug-loaded nanoparticle systems and adult stem cells: a potential marriage for the treatment of malignant glioma? Read more about Drug-loaded nanoparticle systems and adult stem cells: a potential marriage for the treatment of malignant glioma?
